Since its formation in 1921 as a manufacturer of thermometers, Japan-based Terumo has evolved into a global medical device company that has grown in recent years through various business collaborations and strategic mergers and acquisitions.
Since deciding to embark on a course of full-fledged overseas expansion in 1999, Terumo has completed several strategic acquisitions to augment its operations in the medical field. This began with the purchase of US-based 3M’s cardiovascular business unit in 1999; followed by UK-based Vascutek, a manufacturer of vascular grafts, in 2002; Mission Medical, located in the US, to start up a company that develops automated blood collection devices, in 2005; US-based MicroVention, which manufactures and markets coils for the treatment of cerebral aneurysms in 2006; the tissue heart valve business of Kohler Chemie of Germany in March 2007; and the acquisition of CaridianBCT from Gambro to boost its blood business in 2011.
Today, the company’s products are sold in over 160 countries worldwide and are provided through four business segments:
• General Hospital
• Disposable medical devices and medical electronics, including syringes, needles, blood collection tubes, solution sets, IV catheters, infusion pumps, syringe pumps, home parenteral nutrition systems and home oxygen therapy systems. • Pharmaceuticals, including IV solutions, nutritional food, prefilled syringes and continuous ambulatory peritoneal dialysis (CAPD) systems. • Diabetes care, including blood glucose monitoring systems.
• Cardiac and Vascular
• Interventional systems, including angiographic catheters, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, coronary stents and neuro interventional coils. • Cardiovascular systems, including oxygenators, cardiopulmonary bypass systems and a left ventricular assist (LVA) system. • Vascular grafts, including artificial vascular and stent grafts.
• Blood Transfusion
•Blood bags and automated blood processing devices.
• Consumer Healthcare
• Digital thermometers, blood pressure monitors and over-the-counter (OTC) blood glucose monitors.
Terumo operates in more than 80 locations worldwide. Its principal subsidiaries include US-based Terumo Medical, Terumo Cardiovascular Systems (Terumo CVS), TerumoBCT, Harvest Technologies, Terumo Heart and MicroVention, Terumo Europe in Belgium and the UK, Terumo Penpol in India and Vascutek in the UK.
In the year ended 31st March 2012, Terumo generated net income of ¥24.2 billion on net sales of ¥386.7.0 billion. The company has approximately 18,112 employees worldwide.
As of the end of March 2012, trust and banking companies held a combined 26.8 per cent of Terumo’s issued shares. Olympus Corporation, whose Medical Systems division is a leading manufacturer of gastro-intestinal and surgical endoscopes, endotherapy devices, endoscopic ultrasound systems and related products, owned 2.5 per cent of Terumo.
Table Of Contents
Terumo Medical Device Company Intelligence Report Contents
STRATEGIC FOCUS .3
Cardiac and vascular Products 3 General Hospital Products .3 Blood Management Products .4 Espicom view .4
FINANCIAL REVIEW 5
Fiscal Year 2011 Results 5 General Hospital Business .7 Cardiac and vascular Business 8 Blood Management Business 8 Consumer Healthcare Business 8 Five-Year Financial Data 9 Outlook . 10
General Hospital Products . 13 Terumo Medical Products 13 Diabetes care 13 Consumer Products .13 Cardiac and Vascular Products 14 Terumo cvS .14 Terumo interventional Systems 16 Terumo Heart 16 Microvention 17 Terumo europe 18 vascutek .20 Harvest Technologies .23 Blood Management 24 TerumoBcT 24
RESEARCH AND DEVELOPMENT 25
Research Activities 25 RandD Expenditure 25 Research Agreements 26 Daiichi Sankyo 26 Asahi intecc 26 Kirin Pharma (Kyowa Hakko Kirin) .26 Olympus .26 Biocoral 26 Okano industrial corporation 27 Studies and Trials 28 TROFI .28 OSPREY 28
MANUFACTURING . 29
Shanghai angiocare Medical Technology co .31 RS Medical .32 Estech corporation 32 Asahi intecc 32 Small Bone innovations 32 Takeda Pharmaceutical .32 Fuji Pharma 33 Andreas Hettich .33 Biosensors europe 33
MERGERS AND ACQUISITIONS . 34
Onset Medical .34 Harvest Technologies .34 caridianBcT .35
MINORITY INVESTMENTS 36
Fuji Pharma 36
JOINT VENTURES .37
Olympus Terumo Biomaterials 37 Terumo BSn K.K .37
DIVESTITURES . 38
Haemodialysis Operations .38
B Braun 39 Maquet cardiovascular .39 Olympus .39
KEY CORPORATE EVENTS . 40
List of Tables
Recent Key Events .2 Terumo - Annual Financial Results, Fiscal Years 2007-2011 .5 Terumo - Annual Net Sales by Geographic Area, Fiscal Years 2007-2011 6 Terumo - Annual Sales and Operating Income by Business Segment, Fiscal Years 2007-2011 7 Terumo - Five-Year Financial Summary .9 Terumo - Forecast Fiscal Year 2012 Financial Results 10 Terumo Products by Business Segment .12 Terumo - Annual RandD Expenditures, Fiscal Years 2007-2011 .25 Agreements Summary 31 Mergers and Acquisitions Summary 34
List of Charts
Terumo - Annual Sales and Operating Income, Fiscal Years 2007-2011 5 Terumo - Annual Sales by Geographic Area, Fiscal Years 2007-2011 6 Terumo - Annual Sales by Business Segment, Fiscal Years 2007-2011 .7